They stand out like 'ugly ducklings' compared to benign moles, study finds

WEDNESDAY, Jan. 23 (HealthDay News) -- Melanoma may look noticeably different -- like "ugly ducklings", in fact -- compared to other irregular skin moles that are benign, say researchers at the Memorial Sloan-Kettering Cancer Center in New York City.

Rates of melanoma are increasing and early identification enables surgeons to treat the disease by removing the tumor, according to background information in the study.

Melanoma is more common among people with many moles or other skin marks, especially if they're atypical in color, shape or size. It can be a challenge for doctors to distinguish between melanoma and similar-looking moles that are benign.

In this study, the researchers had 34 people -- eight pigmented lesion experts, 13 general dermatologists, five dermatology nurses and eight non-clinical medical staff -- examine photos of the backs of 12 people. They all had at least eight atypical moles, and five of them had one melanoma lesion.

The study participants were asked to evaluate the photos and identify lesions that looked different from all other atypical moles. All five melanomas and only three -- of 140 -- benign lesions (2.1 percent) were identified as being different.

"The malignant melanomas were apparent as being different to at least 85 percent of participants, whereas the agreement rate on the benign lesions perceived as being different was 76 percent at most," the study authors wrote. "Four lesions were generally apparent as completely different, all four being malignant melanomas."

The pigmented lesion experts identified 100 percent of the melanomas, compared with 89 percent for general dermatologists, 88 percent for nurses, and 85 percent for non-clinicians.

"These preliminary findings suggest that the ugly duckling sign may prove to be a useful screening strategy for primary hea
'/>"/>

• AIDS/HIV
• Bioinformatics
• Biotechnology
• Biochemistry
• Cancer
• Cell Biology
• Developmental Biology
• Ecology
• Environment
• Evolution
• Food Technology
• Gene
• Genetics
• Genomics
• Health/Medicine
• Immunology
• Microarray
• Microbiology
• Molecular
• Marine Biology
• Nanobiotechnology
• Neurobiology
• Plant Sciences
• Stem Cell
• Systems Biology
• Virus
• Women Health

• Abortion
• Aches
• ADHD
• Addiction
• Alcohol
• Allergy
• Alternative Medicine
• Alzheimer's Dementia
• Anxiety/Stress
• Arthritis
• Autism
• Bacteria
• Blood
• Bird Flu/Avian Flu
• Bones
• Breast Cancer
• Cancer
• Cardiovascular
• Cervical Cancer
• Chikungunya
• Cholesterol
• Clinical Trials
• Colorectal Cancer
• Conferences
• Crohn's
• Cystic Fibrosis
• Dengue
• Dentistry
• Depression
• Diabetes
• Drug
• Eating Disorders
• Education
• Epilepsy
• Erectile Dysfunction
• Eye Health/Blindness
• Fertility
• Flu/Cold
• GastroIntestinal
• Genetics
• Gout
• Headache/Migraine
• Hearing/Deafness
• HIV/AIDS
• Huntington's Disease
• Hypertension
• Immune System/Vaccines
• Insurance
• Infectious Diseases
• Irritable-Bowel Syndrome
• Internet
• Leukemia
• Lifestyle
• Liver Disease/Hepatitis
• Lung Cancer
• Lupus
• Mad Cow Disease
• Medical Devices
• Medical Students/Training
• Medicare/Medicaid
• Medico
• Men's health
• Mental Health
• MRI/Ultrasound
• MRSA/Drug Resistance
• Multiple Sclerosis
• Muscular Dystrophy
• Neurology
• Nursing
• Nutrition/Diet
• Obesity/Weight Loss
• Pain/Anesthetics
• Parkinson's Disease
• Pediatrics/Children's Health
• Pharma/Biotech Industry
• Pharmacy/Pharmacists
• Pregnancy
• Premature
• Prostate
• Psychology/Psychiatry
• Rehabilitation
• Respiratory/Asthma
• SARS
• Schizophrenia
• Seniors/Aging
• Sexual Health
• Sleep/Sleep Disorders
• Smoking
• Statins
• Stem Cell Research
• Stroke
• Surgery
• Transplants/Organ Donations
• Viruses
• Water - Air Quality
• Women's Health